Elixxer Signs Term Sheet for US$12 Million Institutional Loan


Ryan Allway

January 23rd, 2020

News


MONTREAL, Jan. 22, 2020 (GLOBE NEWSWIRE) — Elixxer Ltd. (TSX-V: ELXR and OTC-QB: ELXIF) (“ELIXXER” or (the “Company”) has signed an indicative term sheet for a US$12 million convertible loan (the “Loan”) from AD Asset Management LLC (“AD”), a U.S.-based fund management company.

Mazen Haddad, Elixxer CEO, stated, “We are very pleased to be working with AD.  This financing is intended to allow Elixxer to execute on our acquisition strategy.”

Ferras Zalt, Elixxer’s Executive Chairman, stated, “Elixxer has been undertaking significant due diligence on a number of revenue-generating assets.  Elixxer’s management is reviewing businesses with revenues that exceed US$50 million per year and show scope for expansion.  Internally, we have been diligent in reducing corporate salaries and overheads.  We are focused at diversification into businesses that can deliver real and immediate value.”

The Loan will be fully secured, mature in three years, and bear interest at an annual rate of 10%, payable semi-annually.  The Loan will be drawn down in three installments of US$4 million each within a twelve-month period.  Elixxer will have the option to pay interest on the Loan in Elixxer shares, at a price per share equal to the volume weighted average trading price (“VWAP”) of the Company’s shares at the time of the interest payment.

AD will have the right to appoint one member to the Company’s Board of Directors.

Elixxer will issue up to 25 million common share purchase warrants to AD, pro rata to each drawdown of the Loan.  The warrants will be exercisable for three years from the date of issuance at a price of $0.10 per share.

Elixxer will have the right to prepay principal and accrued interest on the Loan with a prepayment penalty equal to 5% per annum on the principal prepaid through maturity.  At maturity, the lender will have the option, exercisable in its sole discretion, to convert the outstanding principal and accrued interest into common shares of Elixxer at a price per share equal to the seven-day VWAP of Elixxer’s shares prior to the date of conversion, subject to a minimum price of $0.10 per share.

Elixxer will also issue 20 million common shares to AD Securities America LLC as a fee in connection with the Loan.

The Loan is subject to completion of a definitive agreement containing standard representations and warranties on the part of Elixxer, completion of satisfactory due diligence by AD, approval by the Boards of Directors of Elixxer and AD, and regulatory approval, including that of the TSX Venture Exchange.

About Elixxer Ltd. (www.Elixxer.com)

ELXR Ltd. is a Canadian public company listed on the TSX Venture Exchange (TSX-V: ELXR) and the US OTC-QB exchange (OTCQB: ELXIF).

Through its partners ELXR presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.

For further information please contact:
President, John McMullen, +1-416-803-0698, [email protected]

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice Regarding Forward Looking Statements
This press release may contain forward-looking statements with respect to Elixxer and its operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of Elixxer, including completion of the Loan and any future investment or acquisition, could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in Elixxer’s most recent Management’s Discussion and Analysis filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to Elixxer and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release, and Elixxer has no obligation to update such statements, except to the extent required by applicable securities laws.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading